Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01399918
Title Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

renal cell carcinoma

Therapies

Bevacizumab + Everolimus

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering at Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge New Jersey 07939 United States Details
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Cancer Center @ Suffolk Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering at Mercy Medical Center Rockville Centre New York United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field